# 3·15
Latest news and articles about 3·15
Total: 4 articles found
How China’s Private‑Domain Marketing Industry Uses Fake ‘Medical Experts’ to Sell Overpriced Health Products to Seniors
CCTV‑led reporting exposed a private‑domain marketing network in China that uses paid actors posing as medical experts to sell cheap medicines and supplements at sharply inflated prices to elderly consumers. Video producers, private‑domain operators and contractors create scripted lectures and sell products in closed social‑media channels, prompting likely regulatory scrutiny after the 3·15 consumer‑rights season.
State‑TV ‘3·15’ Exposé Names Duofuduo Subsidiary in Bleached‑Chicken‑Feet Scandal, Raising Governance and Regulatory Risks
CCTV’s consumer‑rights programme named Henan Yifeng, a 54%‑owned subsidiary of listed chemical firm Duofuduo, in an exposé on hydrogen peroxide being used to bleach chicken feet. Duofuduo says Yifeng is properly licensed, accounts for under 1% of group revenue and has no business ties to the processors named, but the related‑party acquisition and state‑TV attention raise governance, reputational and regulatory risks.
CCTV’s 3·15 Exposé Triggers Overnight Crackdown on Food, Health and Consumer Scams Across Chinese Cities
China’s state broadcaster top consumer-rights show exposed multiple consumer-safety and fraud allegations, prompting the national market regulator and municipal authorities to launch immediate joint investigations. Authorities have ordered suspensions, seized products and opened cases across food processing, medical‑health products, online marketing and e-bike rentals, signalling intensified enforcement and higher compliance risk for firms operating in these sectors.
Inside China’s Private‑Domain Sales Machine: Cheap Medicines Repackaged and Sold at Five‑Fold Markups to the Elderly
A 3·15 investigation exposed a private‑domain marketing industry in China that repackages low‑cost medicines and supplements into expensive, persuasive video lectures sold to elderly consumers. The scam hinges on fabricated expert authority and intimate social‑platform channels, yielding markups of up to five times the purchase price and prompting renewed regulatory scrutiny.